Home > Healthcare > Medical Devices > Diagnostic Devices > 3D Medical Imaging Devices Market
3D Medical Imaging Devices Market size was valued at USD 12.9 billion in 2022 and is estimated to account for USD 21.6 billion by 2032. 3D medical imaging devices refer to advanced diagnostic equipment used in the field of medical imaging that can generate three-dimensional (3D) representations of the internal structures of the human body or other subjects of interest.
Additionally, this technology offers precise disease diagnosis, staging, and treatment planning, which is critical in managing chronic illnesses. For instance, by 2050, WHO predicts chronic diseases will cause 86% of 90 million annual deaths, a 90% rise from 2019. Therefore, the increasing prevalence of chronic diseases will drive the demand for 3D medical imaging devices.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
3D Medical Imaging Devices Market Size in 2022: | USD 12.9 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.3% |
2032 Value Projection: | USD 21.6 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 289 |
Tables, Charts & Figures: | 407 |
Segments covered: | Device Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Furthermore, the shift towards minimally invasive medical procedures has driven the need for more accurate and detailed imaging. 3D medical imaging devices, especially in combination with navigation and guidance systems, assist in the planning and execution of minimally invasive surgeries and interventions. Thus, they enable physicians to target and treat specific areas with precision, reducing risks and recovery times for patients.
The COVID-19 pandemic had a considerable positive impact on the 3D medical imaging devices market, as these tools were essential for diagnosing and monitoring COVID-19 patients. They supported telemedicine, aided research on the virus, and improved patient triage and resource allocation. Furthermore, this experience accelerated technological advancements and increased investments in 3D medical imaging devices, highlighting their crucial role in healthcare preparedness and future diagnostics.
Technological advancements in 3D imaging have played a significant role in the growth of market. For instance, the GE Healthcare SIGNA Voyager MRI is a high-field 3T system known for high-quality imaging, advanced diagnostic features, and the capability to acquire 3D and 4D images for detailed anatomical and dynamic visualization. Therefore, these advancements have led to improved image quality, reduced radiation exposure, faster image acquisition, and enhanced diagnostic capabilities. Thus, innovations such as 3D reconstruction, real-time 3D imaging, and hybrid imaging systems have expanded the range of applications and improved patient care.
The market by device type is categorized into hardware and software. The hardware segment is further bifurcated into X-ray, ultrasound, CT, MRI, and mammography. The hardware segment garnered USD 9 billion revenue size in the year 2022.
Therefore, with the increasing demand for more precise diagnostic tools to address the growing healthcare needs and the rising incidence of chronic diseases, the hardware segment is expected to maintain its dominance and continue propelling market growth.
Based on application, the 3D medical imaging devices market is segmented into oncology, cardiology, gynecology and obstetrics, neurology, and other applications. The oncology segment dominated the market and accounted for over 38% market share in the year 2022.
The 3D medical imaging devices market by end-use is categorized into hospitals, diagnostic imaging centers, and other end-users. The hospitals garnered USD 6.7 billion revenue size in the year 2022. The dominance of the segment is attributed due to their central role in providing comprehensive healthcare services, high patient throughput, and the need for advanced diagnostic imaging.
Therefore, with their established presence, ongoing technological advancements, and the continuous need for advanced imaging, hospitals are expected to maintain their leading position in the market and further propel its progress.
U.S. 3D medical imaging devices market accounted for USD 4.8 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
The 3D medical imaging devices industry is consolidated, with key players including Siemens Healthineers, GE Healthcare, Philips Healthcare dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, Siemens Healthineers partnered with Atrium Health's IRCAD North America to enhance surgical training through advanced imaging and curriculum support at the Medical Learning Center of Excellence.
Some of the eminent market participants operating in the 3D medical imaging devices industry include:
These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
Click here to Buy Section of this Report
By Device Type, 2018 – 2032 (USD Million and Units)
By Application, 2018 – 2032 (USD Million)
By End-use, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries: